Gallagher Fiduciary Advisors, LLC Aura Biosciences, Inc. Transaction History
Gallagher Fiduciary Advisors, LLC
- $70.8 Billion
- Q2 2025
A detailed history of Gallagher Fiduciary Advisors, LLC transactions in Aura Biosciences, Inc. stock. As of the latest transaction made, Gallagher Fiduciary Advisors, LLC holds 30,239 shares of AURA stock, worth $178,712. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30,239Holding current value
$178,712% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AURA
# of Institutions
104Shares Held
51.6MCall Options Held
0Put Options Held
0-
Matrix Capital Management Company, LP Waltham, MA6.92MShares$40.9 Million22.54% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA5.1MShares$30.1 Million1.68% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.88MShares$28.8 Million0.05% of portfolio
-
Long Focus Capital Management, LLC San Juan, PR4.62MShares$27.3 Million1.33% of portfolio
-
Suvretta Capital Management, LLC New York, NY4.37MShares$25.8 Million0.94% of portfolio
About Aura Biosciences, Inc.
- Ticker AURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,273,600
- Market Cap $173M
- Description
- Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...